Pharmaceutical

Rgenta Therapeutics’ RGT-61159 gains IND approval to treat cancers

Rgenta has secured approval for its IND application for RGT-61159, an oral small molecule RNA modulator, to treat cancers.

Jul 12, 2024 - 04:00
Rgenta Therapeutics’ RGT-61159 gains IND approval to treat cancers
Rgenta has secured approval for its IND application for RGT-61159, an oral small molecule RNA modulator, to treat cancers.
Read the original article

Tags:

Previous Article

Hong Kong approves Leqembi for Alzheimer’s treatment

Next Article

HarvestHub app tackles supply chain, food insecurity issues

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Ambulance rides for just $100? Government advisers want major billing fixes

Ambulance rides for just $100? Government advisers want...

Nov 9, 2023

Can the government ask social media sites to take down Covid misinformation? SCOTUS will weigh in

Can the government ask social media sites to take down ...

Jan 30, 2024

Opinion: How ARPA-H can master the subtle art of risk-taking

Opinion: How ARPA-H can master the subtle art of risk-t...

Jul 10, 2023